ArticleMaterials today. Bio2025
4'-hydroxychalcone nanofiber hydrogel dressing promotes diabetic chronic wound healing by regulating macrophage polarization via the TLR/IL-17/TNF signaling pathway.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- [Evolution of DFU treatment strategies: from simple coverage with traditional dressings to active modulation with smart materials].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2026Review
- Multifunctional Hydrogels for Diabetic Wound Healing: Design Strategies and Microenvironmental Remodeling Mechanisms.Gels (Basel, Switzerland) · 2026Review
- Chitosan-Based Adhesive Composite Hydrogel to Provide Antibacterial and Anti-Inflammatory Properties for Biomedical Application.Gels (Basel, Switzerland) · 2026Article
- Comprehensive Review of Hydrogel-Mediated Strategies for Diabetic Wound Healing.International journal of molecular sciences · 2026Review
- Regenerative Therapies for Cosmetic Dermatology for Patients with Diabetes Mellitus: Skin Aging, Aesthetic Concerns, and Evidence-Based Best Practices.International journal of molecular sciences · 2026Review
- Novel AI-Driven Precision Strategies in Diabetic Wound Healing: Immunomodulation and Advances in Smart Composite Nanocarriers.Pharmaceutics · 2026Review
- Applications of Nanomaterials in Chronic Wound Healing and Scar Prevention.International journal of nanomedicine · 2026Review
- A Photothermally Triggered Nanoplatform for Multidimensional Antibacterial Therapy and Accelerated Healing of Infected Wounds.International journal of nanomedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The activation and polarization of macrophages play a crucial role in the inflammatory response in chronic diabetic wound healing. Modulating macrophage polarization toward the M2 phenotype can facilitate wound healing. 4'-Hydroxychalcone (4HC) possesses antioxidant and anti-inflammatory properties, and the preparation of novel drugs through electrospun nanofibers and hydrogels can enhance its therapeutic effects. However, the effects of the 4'-hydroxychalcone nanofiber hydrogel dressing (P-4HC) prepared in this study on macrophage polarization and its potential mechanisms in the treatment of diabetic chronic wounds have not yet been elucidated. Objective: This study aimed to investigate the effect of P-4HC on macrophage polarization in diabetic chronic wounds and to elucidate its potential mechanisms of action. Methods: In vitro, cell compatibility tests were conducted using L929, HUVECs, and RAW264.7, along with ROS, scratch assays, tube formation assays, immunofluorescence tests for macrophage phenotypes, flow cytometry, and Western blotting (WB). In vivo, a diabetic mouse skin wound model was established, and HE and Masson staining, immunohistochemical staining of COL3A1, HIF-1a, and VEGF, immunofluorescence staining of CD31, CD86, and CD206, WB, RT-qPCR, and ELISA were conducted. Results: In vitro and in vivo, P-4HC exhibited good cell compatibility, improved tissue hypoxia, and promoted angiogenesis and collagen deposition. It promoted the transition of macrophages from M1 to M2 type, downregulated pro-inflammatory cytokine levels, and upregulated anti-inflammatory cytokines and pro-angiogenic cytokines, thereby promoting the healing of diabetic chronic wounds. Transcriptome analysis indicated that the TLR/IL-17/TNF pathway was the main pathway mediating the effects of P-4HC. P-4HC promoted macrophage polarization toward the M2 phenotype and enhanced wound healing by inhibiting the expression of TLR9, IL-17A, and TRAF1, thereby suppressing the TLR/IL-17/TNF signaling pathway. Conclusion: P-4HC promotes the polarization of macrophages from M1 to M2 phenotype by inhibiting the TLR/IL-17/TNF signaling pathway, thereby suppressing inflammation and mitigating tissue damage. These findings provide a scientific basis for the treatment of chronic diabetic wounds and lay a foundation for exploring new therapeutic strategies for diabetes-induced inflammation based on macrophage polarization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.